Skip to main content

Prostate and Urologic Cancers

Conducts and supports research on the prevention and early detection of prostate and bladder cancers. Develops and supports prevention trials and evaluation of new agents, surrogate biomarkers, and emerging technologies for identifying premalignant lesions.

On This Page

All Heading 2s will automatically be pulled in to this list.
Do not edit the content on this template.

Major Programs

Staff List

Grid View

Photo	Name, Email, Phone	Room	Group(s)/Office
	Asefa, Mela mela.asefa@nih.gov 240-276-6422	5E328	Program Support Assistant \| Breast and Gynecologic Cancer Program Support Assistant \| Prostate and Urologic Cancer
	House, Margaret, RN, B.S.N. margaret.house@nih.gov 240-276-7047	5E306	Deputy Chief \| Prostate and Urologic Cancer
	Parnes, Howard L., M.D. howard.parnes@nih.gov 240-276-7045	5E302	Chief \| Prostate and Urologic Cancer

Grants

PI Name Sort descending	PI Organization	Title	Grant Number	Program Official
Oskeritzian, Carole A	University Of South Carolina At Columbia United States	Novel modalities for prostate cancer screening: mast cells as predictors of disease, disease aggressiveness and marks of disease disparity	5R21CA274021-02	Guillermo Marquez, Ph.D.
Ostrin, Edwin Justin	University Of Tx Md Anderson Can Ctr United States	Validation of blood-based biomarkers for risk assessment of lung cancer among individuals with no smoking history in the PLCO Cohort	1U01CA295902-01A1	Claire Zhu, Ph.D.
Palefsky, Joel Michael	University Of California, San Francisco United States	California-Mexico-Puerto Rico Partnership (CAMPO) Center for Prevention of HPV-related Cancer in HIV+ Populations	3U54CA242646-06S3	Maria Silvina Frech, Ph.D., M.S.
Palesh, Oxana G	Virginia Commonwealth University United States	Multicenter Randomized Controlled Trial of Brief Behavioral Therapy for Cancer Related Insomnia	5R01CA239714-07	Brandy Heckman-Stoddard, Ph.D., M.P.H.
Panda, Satchidananda	Salk Institute For Biological Studies United States	Impact of Time-Restricted Feeding in Reducing Cancer Risk Through Optimizing Mitochondria Function	5R01CA258221-05	Nancy J. Emenaker, Ph.D., RDN, LD, FAND
Panda, Satchidananda	Salk Institute For Biological Studies United States	Impact of Time-Restricted Feeding in Reducing Cancer Risk Through Optimizing Mitochondria Function	5R01CA258221-05	Nancy J. Emenaker, Ph.D., RDN, LD, FAND
Pandharipande, Pari Vijay	Ohio State University United States	Precision Management of Cystic Precursors to Pancreatic Cancer	5R01CA237133-06	Matthew Young, Ph.D.
Panigrahy, Dipak	Beth Israel Deaconess Medical Center United States	Control of cancer cachexia via stimulation of resolution of inflammation	5R01CA276107-02	Marjorie Perloff, M.D.
Panikkar, Rajiv	Geisinger Clinic United States	Geisinger Cancer Institute - NCI Community Oncology Research Program (NCORP)	3UG1CA189847-11S1	Vanessa A. White, M.P.H.
Papachristodoulou, Alexandros	Rutgers Biomedical And Health Sciences United States	Investigating mitochondrial dysfunction in high-risk prostate cancer	4R00CA276713-03	Vignesh Gunasekharan, Ph.D.
Papadopoulos, Nickolas	Johns Hopkins University United States	Multi-analyte Approach for Earlier Detection of Cancers in Non Plasma Biofluids	5U01CA230691-08	Nicholas Hodges, Ph.D.
Park, Youngkyu	Cold Spring Harbor Laboratory United States	Preclinical Models for Cancer Therapeutic Development	5R50CA211506-10	Marjorie Perloff, M.D.
Paskett, Electra D.	Alliance Nctn Foundation United States	Alliance NCORP Research Base	3UG1CA189823-11S3	Brandy Heckman-Stoddard, Ph.D., M.P.H.
Paulovich, Amanda G	Fred Hutchinson Cancer Center United States	Breast-cancer focused biomarker characterization center employing targeted mass spec assays in a CLIA environment	5U2CCA271873-03	Sidney Fu, M.D.
Paulson, Thomas G	Fred Hutchinson Cancer Center United States	The microbiome ecosystem of Barrett's esophagus and progression to cancer	5R21CA259687-02	Matthew Young, Ph.D.